Current Research in Translational Medicine

Papers
(The H4-Index of Current Research in Translational Medicine is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Anti-oxidant, antibacterial, anti-biofilm, and anti-quorum sensing activities of four essential oils against multidrug-resistant bacterial clinical isolates49
Machine learning and artificial intelligence in the service of medicine: Necessity or potentiality?45
Thoughts on cartilage tissue engineering: A 21st century perspective35
CAR T-cell treatment during the COVID-19 pandemic: Management strategies and challenges27
A common TMPRSS2 variant has a protective effect against severe COVID-1926
Mechanistic insights into the role of pyroptosis in rheumatoid arthritis26
Role of Nrf2 in rheumatoid arthritis25
Role of HDAC inhibitors in diabetes mellitus23
Real world experience of approved chimeric antigen receptor T-cell therapies outside of clinical trials20
Age and vitamin D affect the magnitude of the antibody response to the first dose of the SARS-CoV-2 BNT162b2 vaccine19
Human mesenchymal stromal cells from different tissues exhibit unique responses to different inflammatory stimuli19
Sex-mediated effects of ACE2 and TMPRSS2 on the incidence and severity of COVID-19; The need for genetic implementation17
Metformin decreased myocardial fibrosis and apoptosis in hyperhomocysteinemia -induced cardiac hypertrophy15
A review of potential treatments to date in COVID-19 patients according to the stage of the disease15
Mesenchymal stem cells in the fight against viruses: Face to face with the invisible enemy14
Heparin beyond anti-coagulation14
Extracellular vesicles isolated from mesenchymal stromal cells primed with neurotrophic factors and signaling modifiers as potential therapeutics for neurodegenerative diseases14
Anti-TNF containing regimens may be associated with increased risk of Clostridioides difficile infection in patients with underlying inflammatory bowel disease14
0.034283876419067